Literature DB >> 10513709

Unrecognised Mycobacterium tuberculosis bacteraemia among hospital inpatients in less developed countries.

L C McDonald1, L K Archibald, S Rheanpumikankit, S Tansuphaswadikul, B Eampokalap, O Nwanyanawu, P Kazembe, H Dobbie, L B Reller, W R Jarvis.   

Abstract

BACKGROUND: Nosocomial transmission of Mycobacterium tuberculosis is a global public-health concern. Although early clinical recognition of M. tuberculosis in hospital inpatients is critical for effective infection control, such recognition may be difficult in patients with HIV infection. To find out whether M. tuberculosis bacteraemia frequently goes unrecognised, we did a prospective blood-culture survey in an infectious-diseases hospital in Thailand and a general hospital in Malawi.
METHODS: Consecutive febrile (> or = 37.5 degrees C axillary or > or = 38.0 degrees C orally) hospital inpatients (aged > or = 18 years) were enrolled; blood was obtained for mycobacterial culture and HIV testing. Simple diagnostic tests, such as chest radiographs and sputum smears, were ordered by clinicians as deemed necessary, and were carried out with existing local resources.
FINDINGS: Of 344 patients enrolled, 255 (74%) were HIV infected, the median age was 33 years (range 18-87), and 208 (61%) were male. 34 (10%) patients had M. tuberculosis bacteraemia; five of these patients were already on antituberculosis therapy. Only HIV-infected patients had M. tuberculosis bacteraemia. Of the 29 patients with M. tuberculosis bacteraemia who were not already receiving antituberculosis therapy, 13 (45%) had an abnormal chest radiograph or a positive sputum smear. 16 (55%) patients had no additional diagnostic test results to indicate M. tuberculosis infection; 18 (81%) of these had a cough.
INTERPRETATION: In less developed countries where both M. tuberculosis and HIV infections are prevalent, M. tuberculosis bacteraemia may frequently go unrecognised among febrile hospital inpatients.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Asia; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Examinations And Diagnoses; Hiv Infections; Infections; Laboratory Examinations And Diagnoses; Malawi; Measurement; Prevalence; Research Methodology; Research Report; Sampling Studies; Southeastern Asia; Studies; Surveys; Thailand; Tuberculosis; Viral Diseases

Mesh:

Substances:

Year:  1999        PMID: 10513709     DOI: 10.1016/s0140-6736(98)12325-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  39 in total

1.  HIV Treatment in Developing Countries.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

2.  Performance of nucleic acid amplification following extraction of 5 milliliters of whole blood for diagnosis of Mycobacterium tuberculosis bacteremia.

Authors:  John A Crump; Marion J Tuohy; Anne B Morrissey; Habib O Ramadhani; Boniface N Njau; Venance P Maro; L Barth Reller; Gary W Procop
Journal:  J Clin Microbiol       Date:  2011-10-26       Impact factor: 5.948

3.  Epidemiology of Tuberculosis in Malawi.

Authors:  Thomas Nyirenda
Journal:  Malawi Med J       Date:  2006-09       Impact factor: 0.875

4.  Controlled comparison of BacT/Alert MB system, manual Myco/F lytic procedure, and isolator 10 system for diagnosis of Mycobacterium tuberculosis Bacteremia.

Authors:  John A Crump; Anne B Morrissey; Habib O Ramadhani; Boniface N Njau; Venance P Maro; L Barth Reller
Journal:  J Clin Microbiol       Date:  2011-06-08       Impact factor: 5.948

5.  Assessment of mycobacteremia detection as a complementary method for the diagnosis of tuberculosis in HIV-infected patients.

Authors:  J Hernández; A Jaramillo; G I Mejía; P Barón; V Gomez; M A Restrepo; J Robledo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-24       Impact factor: 3.267

6.  Ocular disease in patients with tuberculosis and HIV presenting with fever in Africa.

Authors:  N A V Beare; J G Kublin; D K Lewis; M J Schijffelen; R P H Peters; G Joaki; J Kumwenda; E E Zijlstra
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

7.  Controlled comparison of BACTEC 13A, MYCO/F LYTIC, BacT/ALERT MB, and ISOLATOR 10 systems for detection of mycobacteremia.

Authors:  John A Crump; David C Tanner; Stanley Mirrett; Celeste M McKnight; L Barth Reller
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

8.  In-hospital mortality of disseminated tuberculosis in patients infected with the human immunodeficiency virus.

Authors:  Rodrigo Pires dos Santos; Caroline Deutschendorf; Karin Scheid; Luciano Zubaran Goldani
Journal:  Clin Dev Immunol       Date:  2010-08-04

9.  Severe sepsis in two Ugandan hospitals: a prospective observational study of management and outcomes in a predominantly HIV-1 infected population.

Authors:  Shevin T Jacob; Christopher C Moore; Patrick Banura; Relana Pinkerton; David Meya; Pius Opendi; Steven J Reynolds; Nathan Kenya-Mugisha; Harriet Mayanja-Kizza; W Michael Scheld
Journal:  PLoS One       Date:  2009-11-11       Impact factor: 3.240

10.  Manifestation of tuberculosis in patients with human immunodeficiency virus: a large Indian study.

Authors:  S Rajasekaran; A Mahilmaran; S Annadurai; S Kumar; K Raja
Journal:  Ann Thorac Med       Date:  2007-04       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.